SeaCrest Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

SeaCrest Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-247	Closed	-$42K	–	2071
2019 Q1	$42K	Buy	247 +30	+14%	+$4.46K	0.01%	1005
2018 Q4	$21K	Sell	217 -50	-19%	-$6.56K	﹤0.01%	1227
2018 Q3	$46K	Buy	267 +150	+128%	+$21.6K	0.01%	1046
2018 Q2	$16K	Hold	117	–	–	﹤0.01%	1447
2018 Q1	$13K	Buy	117 +7	+6%	+$880	﹤0.01%	1502
2017 Q4	$15K	Buy	+110	New	+$12.9K	﹤0.01%	1460

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

SeaCrest Wealth Management's GWPH Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 247 shares — an estimated $42K sold.

SeaCrest Wealth Management first reported a position in GWPH in Q4 2017 and held it in 6 quarters. The position peaked at $46K in Q3 2018. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

SeaCrest Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 247 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $42K.
SeaCrest Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 6 quarters.
SeaCrest Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $46K in Q3 2018.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.